Q2 2018 13F Holders as of 30 Jun 2018
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
22,567,367
-
Share change
-
+1,477,423
-
Total reported value
-
$114,259,639
-
Put/Call ratio
-
264%
-
Price per share
-
$5.05
-
Number of holders
-
77
-
Value change
-
+$7,134,149
-
Number of buys
-
44
-
Number of sells
-
28
Institutional Holders of CORBUS PHARMACEUTICALS HLDGS - COM (CRBP) as of Q2 2018
As of 30 Jun 2018,
CORBUS PHARMACEUTICALS HLDGS - COM (CRBP) was held by
77 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,567,367 shares.
The largest 10 holders included
FMR LLC, BlackRock Inc., Knoll Capital Management, LP, VANGUARD GROUP INC, IFP Advisors, Inc, STATE STREET CORP, MORGAN STANLEY, NORTHERN TRUST CORP, GEODE CAPITAL MANAGEMENT, LLC, and Raymond James Financial Services Advisors, Inc..
This page lists
77
institutional shareholders reporting positions in this security
for the Q2 2018 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.